Inhibition of neutrophil exocytosis ameliorates acute lung injury in rats. 2013

Silvia M Uriarte, and Madhavi J Rane, and Michael L Merchant, and Shunying Jin, and Alex B Lentsch, and Richard A Ward, and Kenneth R McLeish
Department of Medicine, University of Louisville, Louisville, KY, USA. silvia.uriarte@louisville.edu

Exocytosis of neutrophil granules contributes to acute lung injury (ALI) induced by infection or inflammation, suggesting that inhibition of neutrophil exocytosis in vivo could be a viable therapeutic strategy. This study was conducted to determine the effect of a cell-permeable fusion protein that inhibits neutrophil exocytosis (TAT-SNAP-23) on ALI using an immune complex deposition model in rats. The effect of inhibition of neutrophil exocytosis by intravenous administration of TAT-SNAP-23 on ALI was assessed by albumin leakage, neutrophil infiltration, lung histology, and proteomic analysis of bronchoalveolar lavage fluid (BALF). Administration of TAT-SNAP-23, but not TAT-control, significantly reduced albumin leakage, total protein levels in the BALF, and intra-alveolar edema and hemorrhage. Evidence that TAT-SNAP-23 inhibits neutrophil exocytosis included a reduction in plasma membrane CD18 expression by BALF neutrophils and a decrease in neutrophil granule proteins in BALF. Similar degree of neutrophil accumulation in the lungs and/or BALF suggests that TAT-SNAP-23 did not alter vascular endothelial cell function. Proteomic analysis of BALF revealed that components of the complement and coagulation pathways were significantly reduced in BALF from TAT-SNAP-23-treated animals. Our results indicate that administration of a TAT-fusion protein that inhibits neutrophil exocytosis reduces in vivo ALI. Targeting neutrophil exocytosis is a potential therapeutic strategy to ameliorate ALI.

UI MeSH Term Description Entries
D008297 Male Males
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005089 Exocytosis Cellular release of material within membrane-limited vesicles by fusion of the vesicles with the CELL MEMBRANE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015696 Gene Products, tat Trans-acting transcription factors produced by retroviruses such as HIV. They are nuclear proteins whose expression is required for viral replication. The tat protein stimulates LONG TERMINAL REPEAT-driven RNA synthesis for both viral regulatory and viral structural proteins. Tat stands for trans-activation of transcription. tat Gene Products,tat Protein,Gene Product, tat,tat Gene Product

Related Publications

Silvia M Uriarte, and Madhavi J Rane, and Michael L Merchant, and Shunying Jin, and Alex B Lentsch, and Richard A Ward, and Kenneth R McLeish
January 2018, Burns & trauma,
Silvia M Uriarte, and Madhavi J Rane, and Michael L Merchant, and Shunying Jin, and Alex B Lentsch, and Richard A Ward, and Kenneth R McLeish
June 2011, Journal of cardiothoracic surgery,
Silvia M Uriarte, and Madhavi J Rane, and Michael L Merchant, and Shunying Jin, and Alex B Lentsch, and Richard A Ward, and Kenneth R McLeish
May 2009, Experimental lung research,
Silvia M Uriarte, and Madhavi J Rane, and Michael L Merchant, and Shunying Jin, and Alex B Lentsch, and Richard A Ward, and Kenneth R McLeish
April 2013, Molecular medicine reports,
Silvia M Uriarte, and Madhavi J Rane, and Michael L Merchant, and Shunying Jin, and Alex B Lentsch, and Richard A Ward, and Kenneth R McLeish
January 2016, International immunopharmacology,
Silvia M Uriarte, and Madhavi J Rane, and Michael L Merchant, and Shunying Jin, and Alex B Lentsch, and Richard A Ward, and Kenneth R McLeish
June 2011, Toxicology and applied pharmacology,
Silvia M Uriarte, and Madhavi J Rane, and Michael L Merchant, and Shunying Jin, and Alex B Lentsch, and Richard A Ward, and Kenneth R McLeish
December 2013, European journal of medical research,
Silvia M Uriarte, and Madhavi J Rane, and Michael L Merchant, and Shunying Jin, and Alex B Lentsch, and Richard A Ward, and Kenneth R McLeish
August 2007, American journal of physiology. Lung cellular and molecular physiology,
Silvia M Uriarte, and Madhavi J Rane, and Michael L Merchant, and Shunying Jin, and Alex B Lentsch, and Richard A Ward, and Kenneth R McLeish
June 1992, Toxicology and applied pharmacology,
Silvia M Uriarte, and Madhavi J Rane, and Michael L Merchant, and Shunying Jin, and Alex B Lentsch, and Richard A Ward, and Kenneth R McLeish
July 2021, American journal of respiratory and critical care medicine,
Copied contents to your clipboard!